Ignite Creation Date:
2024-05-06 @ 7:51 PM
Last Modification Date:
2024-10-26 @ 3:16 PM
Study NCT ID:
NCT06169891
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-12-14
First Post:
2023-11-30
Brief Title:
A Study of Recombinant Anti-IL-1β Humanized Monoclonal Antibody Injection in Chinese Participants With Acute Gout
Sponsor:
Sunshine Guojian Pharmaceutical Shanghai Co Ltd
Organization:
Sunshine Guojian Pharmaceutical Shanghai Co Ltd
Organization Data
Organization:
Sunshine Guojian Pharmaceutical Shanghai Co Ltd
Class:
INDUSTRY
Study ID:
SSGJ-613-AG-III-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Sunshine Guojian Pharmaceutical Shanghai Co Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None